跳至主要内容
临床试验/IRCT2013081912351N2
IRCT2013081912351N2已完成2 期

Evaluation of the effect of crocin capsule on positive,negative,general and cognitive symptomes and prevention of metabolic syndrome in patients with schizophrenia on olanzapin treatment

niversity of Social Welfare and Rehabilitation Sciences0 个研究点目标入组 44 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
Male

入选标准

  • diagnosis of schizophrenia according to DSM-IV-TR criteria; clinical stability without acute phase; no acute medical problem; no coronary heart disease or metabolic syndrome; no neurological disease; no substance abuse or dependency accept nicotine; no usage of anti platelets drugs or ASA or herbal medicines; not being mental retarded; no special slimming or obesity diets Exclusion criteria: Any unwanted side effects that interfere with standard treatment or cause patient refusal of treatment; Need to change olanzapine in the course of treatment for any reason

排除标准

  • 未提供

研究者

发起方
niversity of Social Welfare and Rehabilitation Sciences

相似试验